VHL and nonpapillary renal cell carcinoma: A hallmark of ccRCC is the frequent loss of function of the von Hippel–Lindau (VHL) tumor suppressor gene, which leads to hypoxia-inducible factor (HIF) stabilization and overexpression of vascular endothelial growth factor (VEGF) and thereby promoting angiogenesis (4–6).